By Karen Roman Agendia, Inc. said it will present data to assess treatment decisions on patients with early-stage breast cancer at the San Antonio ...
News
- Agendia To Unveil Enhanced Breast Cancer Therapy at San Antonio - Yahoo
- Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK ... - ABC4 Utah
("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology ... San Antonio Breast Cancer Symposium being held December 10-13, at ...
- Machine learning model predicts breast cancer treatment response - Medical Xpress
... San Antonio Breast Cancer Symposium (SABCS), held December 10–13, 2024. While the use of CDK4/6 inhibitors combined with endocrine therapy have ...
- Medicenna Presents Preclinical Data on MDNA11 as First Step to S - GuruFocus
... Biotechnology MDNAF. Medicenna Presents Preclinical Data on MDNA11 ... San Antonio Breast Cancer Symposium (SABCS), the world's largest breast ...
- Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before ...
Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast ...